Epitinib succinate

CAS : 2252334-12-4

Ref. 3D-CQD33412

Informations sur le produit

• Nom: Epitinib succinate
• CAS: 2252334-12-4

Description

Epitinib succinate is a potent and selective inhibitor of human epidermal growth factor receptor (EGFR) tyrosine kinase, which is overexpressed in many types of cancer. This Chinese analog of the anticancer drug Gefitinib has been shown to inhibit tumor growth and induce apoptosis in cancer cells. Epitinib succinate selectively inhibits EGFR kinases by binding to the ATP-binding site, leading to inhibition of downstream signaling pathways that promote cell proliferation and survival. This drug has been tested in preclinical studies and has shown promising results as a potential treatment for various types of cancer. Epitinib succinate can be detected in urine and is currently being investigated as a potential toxin for targeted cancer therapy.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 548.6 g/mol
• Formule: C₂₈H₃₂N₆O₆
• Degré de pureté: Min. 95%